Neovasc Inc 's ability to collect accounts receivable sequentially worsen to 14.15, indicating more challenging environment then in the third quarter 2021, but still, it is a far cry from any concerns. Neovasc Inc 's Accounts Receivable average collection period in the Dec 31 2021 quarter, has increased to 26 days, from 14 days, in the 0 quarter.

If we take a look into Healthcare sector 618 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2021 from 0 to 4115.

What is Receivable Turnover Ratio?
What is Neovasc Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVCN Receivables Turnover Ratio	(Dec 31 2021) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Receivable Change	123.57 %	-	-	-	-
Y / Y Revenue Change	21.77 %	-	-	-	19.6 %
Receivable Turnover Ratio (TTM)	14.15	25.97	9.1	9.1	9.1
NVCN's Total Ranking	# 4115	# 0	# 4110	# 0	#
Accounts Receivable average collection period days	26	14	40	40	40
Seq. Receivable Change	-	-	-	-	-46.08 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 171
Healthcare Sector	# 619
Overall Market	# 4115

Receivable Turnover Ratio Statistics
High	Average	Low
0.21	0.13	0.04
(Dec 31 2019)		(Dec 31 2021)

NVCN Company Profile • Back to NVCN Efficiency Comparisons • Compare NVCN Receivables Turnover Ratio to its Competitors

Financial Statements
Neovasc Inc 's Accounts Receivable	$ 1 Millions	Visit NVCN's Balance sheet
Neovasc Inc 's Sales TTM	$ 3 Millions	Visit NVCN's Income Statement
Sources of NVCN's Revenues		Visit NVCN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NVCN's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NVCN's Growth Rates	NVCN's Roa	NVCN's Inventory Turnover Ratio	NVCN's Dividend Comparisons
NVCN's Profitability Ratios	NVCN's Roi	NVCN's Asset Turnover Ratio	NVCN's Dividend Growth
NVCN's Valuation Ratios	NVCN's Roe	NVCN's Financial Strength Ratios	NVCN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2021	Receivable at quarter ending Dec 31 2021
Lifeloc Technologies Inc	9.70	$ 7.054 Millions	$ 0.727 Millions
Xencor Inc	9.63	$ 275.111 Millions	$ 28.570 Millions
Protalix Biotherapeutics inc	9.63	$ 38.350 Millions	$ 3.983 Millions
Procyon Corporation	9.61	$ 4.820 Millions	$ 0.501 Millions
Old Ayala Inc	9.53	$ 3.506 Millions	$ 0.368 Millions
Insmed Inc	9.46	$ 188.461 Millions	$ 19.928 Millions
Universal Biosensors Inc	9.42	$ 5.778 Millions	$ 0.613 Millions
Clene Inc	9.39	$ 0.723 Millions	$ 0.077 Millions
Iradimed Corporation	9.38	$ 41.815 Millions	$ 4.460 Millions
United Therapeutics Corporation	9.29	$ 1,685.500 Millions	$ 181.500 Millions
Insulet Corporation	9.28	$ 1,098.800 Millions	$ 118.375 Millions
Myomo Inc	9.13	$ 13.856 Millions	$ 1.518 Millions
Icecure Medical Ltd	9.07	$ 4.138 Millions	$ 0.456 Millions
Rafael Holdings Inc	9.04	$ 4.095 Millions	$ 0.453 Millions
Bridgebio Pharma Inc	9.04	$ 69.716 Millions	$ 7.712 Millions
Isoplexis Corporation	9.03	$ 17.245 Millions	$ 1.911 Millions
Adaptive Biotechnologies Corporation	9.02	$ 154.344 Millions	$ 17.115 Millions
Becton Dickinson And Company	8.99	$ 19,928.000 Millions	$ 2,217.500 Millions
C4 Therapeutics Inc	8.96	$ 45.785 Millions	$ 5.108 Millions
Denali Therapeutics Inc	8.96	$ 48.661 Millions	$ 5.429 Millions
Puma Biotechnology Inc	8.96	$ 253.155 Millions	$ 28.258 Millions
Silk Road Medical Inc	8.89	$ 101.475 Millions	$ 11.415 Millions
Morphic Holding inc	8.80	$ 19.794 Millions	$ 2.250 Millions
Emmaus Life Sciences Inc	8.74	$ 20.610 Millions	$ 2.359 Millions
Resmed Inc	8.74	$ 4,894.681 Millions	$ 560.224 Millions
Henry Schein Inc	8.74	$ 12,401.021 Millions	$ 1,419.551 Millions
Acadia Healthcare Company Inc	8.72	$ 2,454.556 Millions	$ 281.514 Millions
Angiodynamics Inc	8.70	$ 303.275 Millions	$ 34.849 Millions
Inspire Medical Systems inc	8.69	$ 233.394 Millions	$ 26.854 Millions
Nexgel Inc	8.66	$ 1.552 Millions	$ 0.179 Millions

Date modified: 2023-03-24T17:08:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.